相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
Sharareh Gholamin et al.
INNATE IMMUNITY (2020)
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study
Sarah Lapointe et al.
INVESTIGATIONAL NEW DRUGS (2020)
IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma
G. Guo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
CAR T cells and checkpoint inhibition for the treatment of glioblastoma
Steven H. Shen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading
David N. Louis et al.
BRAIN PATHOLOGY (2020)
Novel Therapies for Glioblastoma
Elisa K. Liu et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma
Fabricio Guimaraes Goncalves et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
Anna Kirstein et al.
CANCERS (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
Carmen Balana et al.
NEURO-ONCOLOGY (2020)
Anti-epidermal growth factor receptor therapy for glioblastoma in adults
Adrian Lee et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
Alireza Mansouri et al.
NEURO-ONCOLOGY (2019)
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2019)
Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging
Suyash Mohan et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger et al.
LANCET (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates
David N. Louis et al.
BRAIN PATHOLOGY (2019)
A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM).
Mustafa Khasraw et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Avelumab in newly diagnosed glioblastoma multiforme: The SEJ study.
Francois Henri Jacques et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
Manmeet Singh Ahluwalia et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
Andrew B. Lassman et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM)
Andrew Lassman et al.
NEURO-ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Imaging Glioblastoma Posttreatment Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis
Sara B. Strauss et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2019)
Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques
Bart R. J. van Dijken et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)
Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
Gaurav Verma et al.
NMR IN BIOMEDICINE (2019)
Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
Er Nie et al.
ONCOGENE (2019)
Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone
Florent Tixier et al.
Oncotarget (2019)
Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy
Stefania Elena Navone et al.
WORLD NEUROSURGERY (2019)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation
Tie Li et al.
MOLECULAR CANCER RESEARCH (2018)
Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
Arshad A. Pandith et al.
SCIENTIFIC REPORTS (2018)
Diffusion weighted/Tensor imaging, Functional MRI and Perfusion weighted imaging in Glioblastoma-Foundations and Future
Gayle R. Salama et al.
FRONTIERS IN NEUROLOGY (2018)
Advances in Radiotherapy for Glioblastoma
Justin Mann et al.
FRONTIERS IN NEUROLOGY (2018)
Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact?
Saghir Akhtar et al.
FRONTIERS IN ONCOLOGY (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Preciction
Sohi Bae et al.
RADIOLOGY (2018)
Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
Suneel D. Kamath et al.
FRONTIERS IN ONCOLOGY (2018)
Tumour treating fields in a combinational therapeutic approach
Joshua Branter et al.
Oncotarget (2018)
New Hope in Brain Glioma Surgery: The Role of Intraoperative Ultrasound. A Review
Maria Angela Pino et al.
BRAIN SCIENCES (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Improving the utility of 1H-MRS for the differentiation of glioma recurrence from radiation necrosis
Ian D. Crain et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Skin toxicities associated with tumor treating fields: case based review
Rimas V. Lukas et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Glioblastoma subtypes revisited
Peter Sidaway
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T. Blumenthal et al.
NEURO-ONCOLOGY (2017)
Glioblastoma Treatment in the Elderly
Masaki Okada et al.
NEUROLOGIA MEDICO-CHIRURGICA (2017)
The Role of Hypoxia in Glioblastoma Invasion
Ana Rita Monteiro et al.
CELLS (2017)
Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images
Peter D. Chang et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria
Mayur Sharma et al.
CHINESE CLINICAL ONCOLOGY (2017)
Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up
Hugues Duffau
ACTA NEUROCHIRURGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
TTFields: where does all the skepticism come from?
Wolfgang Wick
NEURO-ONCOLOGY (2016)
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
Wen-Juan Huang et al.
ONCOLOGY LETTERS (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment
Rasime Kalkan
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Case-Based Review: newly diagnosed glioblastoma
Derek R. Johnson et al.
NEURO-ONCOLOGY PRACTICE (2015)
Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies
Abhishek Ray et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations
Susan V. Ellor et al.
JOURNAL OF LAW MEDICINE & ETHICS (2014)
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Comparison of Three Different MR Perfusion Techniques and MR Spectroscopy for Multiparametric Assessment in Distinguishing Recurrent High-Grade Gliomas from Stable Disease
Achim Seeger et al.
ACADEMIC RADIOLOGY (2013)
Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide
J. Sherriff et al.
BRITISH JOURNAL OF RADIOLOGY (2013)
Description of selected characteristics of familial glioma patients - Results from the Gliogene Consortium
Siegal Sadetzki et al.
EUROPEAN JOURNAL OF CANCER (2013)
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective
Benedikt Wiestler et al.
NEURO-ONCOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
NADP+-dependent IDH1R132 mutation and its relevance for glioma patient survival
Nishita M. S. Baldewpersad Tewarie et al.
MEDICAL HYPOTHESES (2013)
Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
Takahiro Oike et al.
PLOS ONE (2013)
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
C-H Fan et al.
CELL DEATH & DISEASE (2013)
Hypoxic Cell Waves Around Necrotic Cores in Glioblastoma: A Biomathematical Model and Its Therapeutic Implications
Alicia Martinez-Gonzalez et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2012)
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival Clinical article
Daniel Orringer et al.
JOURNAL OF NEUROSURGERY (2012)
Genetic Analysis of Cytomegalovirus in Malignant Gliomas
Bornali Bhattacharjee et al.
JOURNAL OF VIROLOGY (2012)
Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target
Changcun Guo et al.
CURRENT OPINION IN NEUROLOGY (2011)
Radiographic patterns of relapse in glioblastoma
Marc C. Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Validation of Functional Diffusion Maps (fDMs) as a Biomarker for Human Glioma Cellularity
Benjamin M. Ellingson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
F. M. Iwamoto et al.
NEUROLOGY (2009)
The end-of-life hospital setting in patients with glioblastoma
Stefan Oberndorfer et al.
JOURNAL OF PALLIATIVE MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
Venous thromboembolism and survival in patients with high-grade glioma
Ralph Simanek et al.
NEURO-ONCOLOGY (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds
NG Burnet et al.
BRITISH JOURNAL OF CANCER (2005)
Overview: Brain tumour diagnosis and management/Royal College of physicians guidelines
R Grant
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Cost of migration: Invasion of malignant gliomas and implications for treatment
A Giese et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C→A:T mutations of the TP53 tumor suppressor gene
M Nakamura et al.
CARCINOGENESIS (2001)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
NAD(P)H, a directly operating antioxidant?
M Kirsch et al.
FASEB JOURNAL (2001)
分享论文
